A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Baohui Han,Kai Li,Yizhuo Zhao,Qiming Wang,Li Zhang,Jianhua Shi,Zhehai Wang,Jianxing He,Yuankai Shi,Yin Cheng,Weiqiang Chen,Xiuwen Wang,Yi Luo,Kejun Nan,Faguang Jin,Jian Dong,Baolan Li,Jianying Zhou,Yinlan Chen,Donglin Wang,Xin Zhou,Yan Yu,Liming Chen,Anwen Liu,Jianjin Huang,Cheng Huang,Bangwei Cao,Jun Chen,Rui Ma,Zhuang Yu,Cuimin Ding,Hongbing Wang Journal of Thoracic Oncology（2017）
关键词
NSCLC,Anlotinib,multi-targeted tyrosine kinase inhibitor
AI 理解论文
溯源树
样例
